These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38203404)

  • 61. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
    Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
    Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
    Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
    [No Abstract]   [Full Text] [Related]  

  • 63. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Manifestations of Pulmonary Mucormycosis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation: A 21-Case Series Report and Literature Review.
    Bao J; Liu C; Dong Y; Xu Y; Wang Z; Sun K; Xi W; Wang K; Gong P; Gao Z
    Can Respir J; 2022; 2022():1237125. PubMed ID: 35692949
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation.
    Vythoulkas D; Tsirigotis P; Griniezaki M; Konstantellos I; Lazana I
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765638
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.
    Gilles R; Herling M; Holtick U; Heger E; Awerkiew S; Fish I; Höller K; Sierra S; Knops E; Kaiser R; Scheid C; Di Cristanziano V
    Med Microbiol Immunol; 2017 Oct; 206(5):355-362. PubMed ID: 28702856
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
    Wetzel L; Wittig S; Gruhn B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopy.
    Karakioulaki M; Martinez M; Medinger M; Heim D; Passweg JR; Tsakiris DA
    Int J Lab Hematol; 2020 Apr; 42(2):145-151. PubMed ID: 31769937
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical significance of plasminogen activator inhibitor-1 (PAI-1) in the early development of HSCT-associated thrombotic complications.].
    Han Y; Lu XX; Wu DP; Sun AN; Zhang W; Hu XH; Gao HL; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):731-4. PubMed ID: 20137306
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy.
    Masuzawa N; Nishimura A; Kitani T; Tamagaki K; Sugitani M; Nagoshi H; Kuroda J; Konishi E
    Pathol Int; 2017 Dec; 67(12):620-625. PubMed ID: 28940837
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Laskin BL; Maisel J; Goebel J; Yin HJ; Luo G; Khoury JC; Davies SM; Jodele S
    Transplantation; 2013 Jul; 96(2):217-23. PubMed ID: 23698598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clinical analysis of 9 patients with transplant-related thrombotic microangiopathy].
    Zhang BL; Zhou J; Gui RR; Zu YL; Zhang YL; Song YP
    Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):423-427. PubMed ID: 31159520
    [No Abstract]   [Full Text] [Related]  

  • 74. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
    Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li JM; Waller EK
    PLoS One; 2017; 12(9):e0184254. PubMed ID: 28953925
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.
    Shayani S; Palmer J; Stiller T; Liu X; Thomas SH; Khuu T; Parker PM; Khaled SK; Forman SJ; Nakamura R
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):298-304. PubMed ID: 23078784
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
    Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
    Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT.
    Elfeky R; Lucchini G; Lum SH; Ottaviano G; Builes N; Nademi Z; Battersby A; Flood T; Owens S; Cant AJ; Young H; Greener S; Walsh P; Kavanagh D; Annavarapu S; Rao K; Amrolia P; Chiesa R; Worth A; Booth C; Skinner R; Doncheva B; Standing J; Gennery AR; Qasim W; Slatter M; Veys P
    Blood Adv; 2020 Jun; 4(11):2418-2429. PubMed ID: 32492158
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
    Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical characteristics and risk factors of pericardial effusion after hematopoietic stem cell transplantation in children with thalassemia major].
    Yang CL; Wang XD; Zhou XH; Wang CJ; Zhang XL; Li Y; Yu Y; Liu SX
    Zhonghua Er Ke Za Zhi; 2022 Apr; 60(4):323-328. PubMed ID: 35385938
    [No Abstract]   [Full Text] [Related]  

  • 80. [The risk factors and prognosis of transplant-associated thrombotic microangiopathy following acute graft-versus-host disease].
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2013 Feb; 52(2):156-60. PubMed ID: 23967613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.